Home / Investors / Events

Upcoming Events

Sep 24 2019 8:00 am ET

Oppenheimer Fall Summit Focused on Specialty Pharma & Rare Disease Companies

September 24, 2019 at 8:00 am ET


Past Events

Sep 10 2019 9:10 am ET

H.C. Wainwright 21st Annual Global Investment Conference

September 10, 2019 at 9:10 am ET

Sep 5 2019 12:45 pm ET

Citi’s 14th Annual Biotech Conference

September 5, 2019 at 12:45 pm ET

Aug 7 2019 4:30pm ET

Second Quarter 2019 Financial Results Conference Call

August 7, 2019 at 4:30pm ET

Jun 19 2019 8:00 am ET

Raymond James Life Sciences and MedTech Conference

June 19, 2019 at 8:00 am ET

Lotte New York Palace in New York City

Jun 12 2019 9:00am PT

2019 Annual Meeting of Stockholders

June 12, 2019 at 9:00am PT

Newark, CA

Jun 11 2019 8:00 am ET

Conference Call to Discuss Topline 12-Week Data from an Ongoing Phase 2b Study of Seladelpar in Patients with Nonalcoholic Steatohepatitis

June 11, 2019 at 8:00 am ET

May 18 2019

Digestive Disease Week® (DDW)

May 18 - May 21, 2019

San Diego, California

May 8 2019 4:30 pm ET

First Quarter 2019 Financial Results Conference Call

May 8, 2019 at 4:30 pm ET

Apr 10 2019

The International Liver Conference™ 2019

April 10 - April 14, 2019

Vienna, Austria

Oral Presentation

April 12th 16:15 - 16:30

1“Seladelpar for the treatment of primary biliary cholangitis: experience with 25 cirrhotic patients”
Marlyn Mayo, Christopher Bowlus, Michael Galambos, Guy Neff, Palak Trivedi, Aparna Goel, Joseph Odin, Bruce Bacon, Brian Borg, Stuart Gordon, Aliya Gulamhusein, Stephen Harrison, Cynthia Levy, Carmen Stanca, John Vierling, Alexandra Steinberg, Monika Varga, Jaidyn Nguyen, Sandrin Bergheanu, Yun-Jung Choi, Mary Standen, Pol Boudes     

Clinical Poster Presentations

April 12th 9:00 - 17:00

2“Pharmacokinetics, safety, and tolerability of seladelpar in subjects with hepatic impairment”                                                      
Lily Mao, Robert Martin, Alexandra Steinberg, Patricia Rohane, Jaidyn Nguyen, Mary Standen, Pol Boudes      

3“Treatment of patients with primary biliary cholangitis with seladelpar for 52 weeks improves predicted transplant-free survival”
Carla Fiorella Murillo Perez, Pol Boudes, Alexandra Steinberg, Monika Varga, Yun-Jung Choi, Aliya Gulamhusein, Gideon Hirschfield, Bettina Hansen

Preclinical Poster Presentation

April 12th 9:00 - 17:00

4“Comparison of seladelpar and combinations with liraglutide or selonsertib for improvement of fibrosis and NASH in a diet-induced and biopsy-confirmed mouse model of NASH”
Yun-Jung Choi, Jiangao Song, Jeff D. Johnson, Marc K. Hellerstein, Charles McWherter

Mar 28 2019

ROTH Battle of NASH Thrones Spring Investor Conference

March 28, 2019

Time: 8:00 am Eastern Time
Format: Panel: 12 Months of Data - 2019 Is the Year for FXR and PPAR Clinical Readouts

Time: 4:00pm Eastern Time
Format: Panel: Why MRI May Hold the Key to the Kingdom in Diagnosis and Drug Development

Mar 27 2019 1:00 pm CT

Oppenheimer’s Biotech Summit by the Lake

March 27, 2019 at 1:00 pm CT

Mar 20 2019 8:35 am ET

Oppenheimer 29th Annual Healthcare Conference

March 20, 2019 at 8:35 am ET

Mar 18 2019

31st Annual ROTH Conference

March 18, 2019

Time: 9:30am Pacific Time
Format: Panelist: Why Knowing NASH as a Generalist Can Make You Rich in 2019

Time: 12:00pm Pacific Time
Format: Fireside Chat